https://charts.traderzeitung.de/phases/US55287L1017 string(1448) "{"isin":"US55287L1017","name":"MBX Biosciences Inc","stock_id_xnas":58839822,"stock_id_xnys":null,"generated_at":"2026-08-21 18:01:00","days":[{"date":"2026-08-19","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":68,"close_at":"2026-08-19 15:28:00","complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":68.34,"close_at":"2026-08-19 21:59:00","complete":true,"perf_pct":0.5},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-08-20","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":68,"close_at":"2026-08-20 14:47:00","complete":true,"perf_pct":-0.4975},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":66.39,"close_at":"2026-08-20 21:59:00","complete":true,"perf_pct":-2.3676},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-08-21","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":66,"close_at":"2026-08-21 14:17:00","complete":true,"perf_pct":-0.5874},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":66.81,"close_at":"2026-08-21 18:00:00","complete":false,"perf_pct":1.2273},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]}]}"

MBX Biosciences Aktie News & Nachrichten

[WKN: A40BRQ | Symbol: MBX]

Realtimekurs

Vorbörsliche Indikationen

Regulärer Handel

Nachbörslicher Handel

10J

Alles

Artikel aus der Redaktion der Trader-Zeitung

10.04.2025 um 16 Uhr

MBX Biosciences

MBX Biosciences (MBX): JMP Securites sieht knapp 500 % Kurspotenzial und verweist auf hohen ungedeckten Bedarf bei Nebenschilddrüsenerkrankung

MBX Biosciences Inc. (MBX) hat sich auf die Entwicklung von Peptidtherapien zur Behandlung von endokrinen...

MBX Biosciences Nachrichtenticker öffnen

MT Newswires 10.08.2026 12:12 Uhr

Truist passt das Kursziel für MBX Biosciences von 70 $ auf 88 $ an und behält das Buy-Rating bei

06:11 AM EDT, 08/10/2026 (MT Newswires) -- MBX Biosciences (MBX) has an average rating of buy and mean price target of $88.40, according to analysts p

MT Newswires 06.08.2026 16:43 Uhr

MBX Biosciences Aktien fallen nach Ausweitung des Q2-Verlusts

10:40 AM EDT, 08/06/2026 (MT Newswires) -- MBX Biosciences (MBX) shares were about 1.0% lower in Thursday trading following its Q2 results. Earlier, t

MT Newswires 06.08.2026 14:25 Uhr

--Earnings Flash (MBX) MBX Biosciences verzeichnet im Q2 Nettoverlust von 0,63 je Aktie laut FactSet-Schätzung von 0,78 Verlust

MT Newswires 13.07.2026 22:40 Uhr

MBX Biosciences ernennt Steve Hoerter zum CEO; Kent Hawryluk tritt zurück

04:39 PM EDT, 07/13/2026 (MT Newswires) -- MBX Biosciences (MBX) ernannte am Montag den geschäftsführenden Vorsitzenden Steve Hoerter zum Vorsitzenden

MT Newswires 12.06.2026 13:56 Uhr

MBX Biosciences' Phase-2-Studie von Canvuparatide erreicht primären Endpunkt; Aktien fallen vorbörslich

07:54 AM EDT, 06/12/2026 (MT Newswires) -- MBX Biosciences (MBX) teilte am Freitag mit, dass die Avail Phase-2-Studie des einmal wöchentlich verabreic